BridgeBio Pharma, Inc. (BBIO)
68.56
+0.44
(+0.65%)
USD |
NASDAQ |
Oct 23, 16:00
68.53
-0.03
(-0.04%)
After-Hours: 20:00
BridgeBio Pharma Price : 68.56 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 67.69 | 68.86 | 67.02 | 68.56 | 2.403M |
| Oct 22, 2026 | 67.48 | 69.32 | 67.07 | 68.12 | 2.780M |
| Oct 21, 2026 | 68.04 | 68.79 | 67.54 | 67.74 | 3.009M |
| Oct 20, 2026 | 68.28 | 69.00 | 67.25 | 67.55 | 2.733M |
| Oct 19, 2026 | 67.35 | 68.52 | 66.72 | 67.94 | 2.292M |
| Oct 16, 2026 | 67.03 | 67.04 | 65.26 | 66.39 | 2.056M |
| Oct 15, 2026 | 65.67 | 67.76 | 65.44 | 67.13 | 2.639M |
| Oct 14, 2026 | 63.34 | 65.36 | 62.86 | 64.94 | 2.702M |
| Oct 13, 2026 | 66.05 | 66.05 | 62.94 | 63.30 | 2.709M |
| Oct 12, 2026 | 65.35 | 66.42 | 65.20 | 65.75 | 1.779M |
| Oct 09, 2026 | 65.04 | 65.94 | 64.34 | 65.35 | 1.847M |
| Oct 08, 2026 | 66.39 | 66.40 | 63.70 | 65.04 | 3.362M |
| Oct 07, 2026 | 66.78 | 67.58 | 66.15 | 66.50 | 2.064M |
| Oct 06, 2026 | 67.75 | 68.12 | 65.70 | 66.96 | 3.710M |
| Oct 05, 2026 | 67.40 | 68.08 | 65.46 | 66.14 | 2.169M |
| Oct 02, 2026 | 67.10 | 68.68 | 66.23 | 67.25 | 2.646M |
| Oct 01, 2026 | 65.72 | 67.26 | 65.16 | 66.91 | 3.550M |
| Sep 30, 2026 | 66.14 | 67.32 | 65.61 | 65.80 | 2.822M |
| Sep 29, 2026 | 66.38 | 67.16 | 65.82 | 65.97 | 3.597M |
| Sep 28, 2026 | 65.07 | 67.34 | 64.36 | 66.61 | 2.969M |
| Sep 25, 2026 | 66.50 | 67.07 | 64.84 | 65.57 | 2.090M |
| Sep 24, 2026 | 65.85 | 67.30 | 65.32 | 66.28 | 4.272M |
| Sep 23, 2026 | 69.23 | 70.00 | 64.90 | 65.71 | 3.678M |
| Sep 22, 2026 | 66.90 | 69.77 | 66.61 | 69.23 | 3.783M |
| Sep 21, 2026 | 67.01 | 67.33 | 65.78 | 66.58 | 3.167M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Alnylam Pharmaceuticals, Inc. | 224.03 |
| Pfizer Inc. | 30.03 |
| Ionis Pharmaceuticals, Inc. | 42.93 |
| Cytokinetics, Inc. | 61.23 |
| Vertex Pharmaceuticals, Inc. | 523.93 |
Price Related Metrics
| PS Ratio | 18.65 |
| Earnings Yield | -5.21% |
| Market Cap | 13.39B |